FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2330791837> ?p ?o ?g. }

• W2330791837 endingPage "614" @default.
• W2330791837 startingPage "608" @default.
• W2330791837 abstract "Abnormal deposition of amyloid-β and hyperphosphorylated tau protein in the brain are the pathologic hallmark of Alzheimer disease (AD). Noninvasive detection of the lesions is considered an effective tool for early diagnosis and staging of AD. In the past decade, we developed 2-arylquinoline (2-AQ) derivatives as PET tau tracers. In this study, we synthesized new derivatives and evaluated their properties.Fifteen 2-AQ derivatives were labeled with (18)F, and their binding to tau lesions was evaluated by autoradiography using AD brain sections. The binding affinity for the AD brain homogenates was assessed by an in vitro competitive binding assay with (18)F-THK-5105. (18)F-labeled derivatives were injected into mice via the tail vein, and their pharmacokinetics over the first 120 min after injection were evaluated by an ex vivo biodistribution study. Tracer metabolism analysis was also assessed in mice.The average logP value was 2.80. This study revealed that 2-AQ derivatives having (18)F-labeled side chains on benzene or position 7 of the quinoline showed significantly lower binding affinity for tau than 6-substituted quinoline derivatives. The 2-AQ derivatives labeled with (18)F-fluoroethoxy, (18)F-fluoropropoxy, and (18)F-fluoro-polyethyleneglycol groups displayed slow clearance from blood or a high accumulation in bone, whereas derivatives labeled with the (18)F-(3-fluoro-2-hydroxy)propoxyl group did not. (18)F-THK-5151 had outstanding tau binding properties and pharmacokinetics. Furthermore, the properties of its optically pure (S)-enantiomer (THK-5351) were superior to those of the (R)-enantiomer (THK-5451), particularly in terms of its clearance from the brain and its resistance to defluorination in mice.The structure-activity relationship study of 2-AQ derivatives revealed the optimal structural features for tau imaging agents. On the basis of these results, (18)F-THK-5351 ((S)-(18)F-THK-5151) was selected as a potential agent for tau imaging." @default.
• W2330791837 created "2016-06-24" @default.
• W2330791837 creator A5015270336 @default.
• W2330791837 creator A5015483676 @default.
• W2330791837 creator A5017027985 @default.
• W2330791837 creator A5028540036 @default.
• W2330791837 creator A5035847289 @default.
• W2330791837 creator A5046715253 @default.
• W2330791837 creator A5063415107 @default.
• W2330791837 creator A5065225018 @default.
• W2330791837 creator A5088939137 @default.
• W2330791837 date "2015-12-23" @default.
• W2330791837 modified "2023-10-06" @default.
• W2330791837 title "Structure–Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease" @default.
• W2330791837 cites W1895715710 @default.
• W2330791837 cites W1930101555 @default.
• W2330791837 cites W1963599567 @default.
• W2330791837 cites W1965122120 @default.
• W2330791837 cites W1976923044 @default.
• W2330791837 cites W1993571512 @default.
• W2330791837 cites W2000473213 @default.
• W2330791837 cites W2009870816 @default.
• W2330791837 cites W2024655824 @default.
• W2330791837 cites W2048332130 @default.
• W2330791837 cites W2054089714 @default.
• W2330791837 cites W2090523774 @default.
• W2330791837 cites W2093022413 @default.
• W2330791837 cites W2096963202 @default.
• W2330791837 cites W2100442068 @default.
• W2330791837 cites W2100982663 @default.
• W2330791837 cites W2103179040 @default.
• W2330791837 cites W2106718411 @default.
• W2330791837 cites W2107525575 @default.
• W2330791837 cites W2112136536 @default.
• W2330791837 cites W2113120581 @default.
• W2330791837 cites W2117029279 @default.
• W2330791837 cites W2126086024 @default.
• W2330791837 cites W2149281406 @default.
• W2330791837 cites W2159377066 @default.
• W2330791837 cites W2162142674 @default.
• W2330791837 cites W2219920450 @default.
• W2330791837 cites W2313240329 @default.
• W2330791837 cites W4235092975 @default.
• W2330791837 doi "https://doi.org/10.2967/jnumed.115.166652" @default.
• W2330791837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26697966" @default.
• W2330791837 hasPublicationYear "2015" @default.
• W2330791837 type Work @default.
• W2330791837 sameAs 2330791837 @default.
• W2330791837 citedByCount "54" @default.
• W2330791837 countsByYear W23307918372016 @default.
• W2330791837 countsByYear W23307918372017 @default.
• W2330791837 countsByYear W23307918372018 @default.
• W2330791837 countsByYear W23307918372019 @default.
• W2330791837 countsByYear W23307918372020 @default.
• W2330791837 countsByYear W23307918372021 @default.
• W2330791837 countsByYear W23307918372022 @default.
• W2330791837 countsByYear W23307918372023 @default.
• W2330791837 crossrefType "journal-article" @default.
• W2330791837 hasAuthorship W2330791837A5015270336 @default.
• W2330791837 hasAuthorship W2330791837A5015483676 @default.
• W2330791837 hasAuthorship W2330791837A5017027985 @default.
• W2330791837 hasAuthorship W2330791837A5028540036 @default.
• W2330791837 hasAuthorship W2330791837A5035847289 @default.
• W2330791837 hasAuthorship W2330791837A5046715253 @default.
• W2330791837 hasAuthorship W2330791837A5063415107 @default.
• W2330791837 hasAuthorship W2330791837A5065225018 @default.
• W2330791837 hasAuthorship W2330791837A5088939137 @default.
• W2330791837 hasBestOaLocation W23307918371 @default.
• W2330791837 hasConcept C112705442 @default.
• W2330791837 hasConcept C150903083 @default.
• W2330791837 hasConcept C185592680 @default.
• W2330791837 hasConcept C202751555 @default.
• W2330791837 hasConcept C207001950 @default.
• W2330791837 hasConcept C2777807558 @default.
• W2330791837 hasConcept C2778172261 @default.
• W2330791837 hasConcept C55493867 @default.
• W2330791837 hasConcept C71924100 @default.
• W2330791837 hasConcept C86803240 @default.
• W2330791837 hasConcept C98274493 @default.
• W2330791837 hasConceptScore W2330791837C112705442 @default.
• W2330791837 hasConceptScore W2330791837C150903083 @default.
• W2330791837 hasConceptScore W2330791837C185592680 @default.
• W2330791837 hasConceptScore W2330791837C202751555 @default.
• W2330791837 hasConceptScore W2330791837C207001950 @default.
• W2330791837 hasConceptScore W2330791837C2777807558 @default.
• W2330791837 hasConceptScore W2330791837C2778172261 @default.
• W2330791837 hasConceptScore W2330791837C55493867 @default.
• W2330791837 hasConceptScore W2330791837C71924100 @default.
• W2330791837 hasConceptScore W2330791837C86803240 @default.
• W2330791837 hasConceptScore W2330791837C98274493 @default.
• W2330791837 hasIssue "4" @default.
• W2330791837 hasLocation W23307918371 @default.
• W2330791837 hasLocation W23307918372 @default.
• W2330791837 hasOpenAccess W2330791837 @default.
• W2330791837 hasPrimaryLocation W23307918371 @default.
• W2330791837 hasRelatedWork W1966980125 @default.
• W2330791837 hasRelatedWork W1984816716 @default.
• W2330791837 hasRelatedWork W2068131347 @default.

• next